INTRODUCTION 1,004 deaths had complete data (79.1%) and were analysed. Median age of the study population was 72 years (IQR: 62-79, range: 19-99), with males constituting 57.2% of the cohort. Diabetes (61.6%), hypertension (36.9%), and coronary artery disease (14%) were the predominant comorbidities, with 37.2% having multiple comorbidities. COVID-19 pneumonia was the primary cause of death (83%). Most deaths (78.3%) occurred among unvaccinated individuals, while a smaller proportion (21.7%) occurred among those who had received at least one vaccine dose. Unvaccinated individuals were older, had longer hospital stays, and exhibited more severe symptoms compared to their vaccinated counterparts. CONCLUSIONS: Most deaths occurred among older adults and individuals with diabetes or hypertension. Strengthening vaccination outreach and clinical management of high-risk groups remains important. The lower proportion of vaccinated individuals observed among the deceased is notable; however, further population-level data are required to formally evaluate vaccine effectiveness. These descriptive findings underscore the need to prioritise high-risk populations in vaccination campaigns. These findings provide guidance for strengthening pandemic preparedness in resource-constrained settings, with potential applications across similar healthcare systems globally. CLINICAL TRIAL NUMBER: Not applicable.
Silva et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: